Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Third party research

Prevas: Tough start in Finland - ABG

Prevas

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
1% organic sales decline y-o-y
Enmac had negative EBITA in Q3, actions taken
Adj. EBITA down 11-7% for '24e-'26e


Q3: Sales -10% and adj. EBITA -34% vs. ABGSCe

Prevas experienced a challenging Q3, with an organic sales decline of 1% and adj. EBITA of SEK 26.5m (31.1m), equal to an adj. EBITA margin of 7.5% (10%). In addition, the recently acquired Enmac unit struggled in a weak Finnish market characterised by customers delaying their investment decisions. This led Enmac to post negative EBITA and Prevas has decided to temporarily lay off 23 FTEs. This was not what we were expecting, and group sales were 10% below (we expected 2.5% organic growth) ABGSCe, with adj. EBITA 34% below. The majority of the deviation was caused by weaker M&A contribution, although core Prevas was also below on organic growth and likely also saw lower utilisation and profitability vs. Q2.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.